figure_review
TL2 Member · Haarlem, NL
UK-based. Mostly the access and pricing categories.
Joined 7 October 2024 · last posted 1d · groups: regional-uk
91 posts, newest first. Showing up to 150.
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #33 · Evidence › Study critique · 27 Jul 2026 · 31 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #46 · Clinical › Prescriber conversations · 25 Jul 2026 · 18 likes What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of any adverse effects you have experienced with other…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #103 · Analytics › Home & field testing · 21 Jul 2026 · 1 like What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #50 · Practice › Side effects · 19 Jul 2026 · 0 likes This follows post #47 rather than contradicting it. Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site…
-
Which categories are strict and which are relaxed, honestly Replied, post #26 · Start Here › Welcome · 18 Jul 2026 · 26 likes post #25 is right about the mechanism and I think understates the practical bit. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is…
-
Seven-day rolling means and why weekly readings mislead Replied, post #48 · Outcomes › Progress reports · 17 Jul 2026 · 7 likes post #47 is right about the mechanism and I think understates the practical bit. Protein intake and resistance training: both self-reported and therefore optimistic in…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #116 · Outcomes › Body composition · 17 Jul 2026 · 15 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #6 · Sourcing › Regulatory · 10 Jul 2026 · 0 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
A site rotation scheme that is easy enough to actually follow Replied, post #107 · Practice › Administration · 6 Jul 2026 · 15 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #59 · Sourcing › Independent verification · 2 Jul 2026 · 22 likes Worth separating two things that post #55 runs together. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is…
-
How shortages have affected compounding permissions Replied, post #6 · Access › Shortages · 30 Jun 2026 · 9 likes post #5 is right about the mechanism and I think understates the practical bit. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #49 · Compounds › Secretagogues & GH axis · 25 Jun 2026 · 24 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #25 · Evidence › Trials · 25 Jun 2026 · 14 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #18 · Analytics › Impurities & related substances · 23 Jun 2026 · 0 likes Worth separating two things that post #14 runs together. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #85 · Sourcing › Vendor reports · 16 Jun 2026 · 3 likes post #84 answers the question as asked. The question underneath it is different. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the…
-
Submitting a sample: the process end to end Replied, post #20 · Sourcing › Independent verification · 16 Jun 2026 · 4 likes post #19 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
What to include when your question involves a chromatogram — one year on Replied, post #36 · Start Here › How to Ask · 13 Jun 2026 · 0 likes This follows post #33 rather than contradicting it. Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #25 · Analytics › HPLC & UHPLC · 12 Jun 2026 · 15 likes On post #21 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #56 · Wellbeing › Sleep · 11 Jun 2026 · 18 likes post #55 is right about the mechanism and I think understates the practical bit. When sleep problems need attention: if sleep does not improve as weight loss continues…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #76 · Data & Tools › Datasets · 6 Jun 2026 · 3 likes Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #28 · Compounds › Retatrutide · 30 May 2026 · 7 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #29 · Analytics › HPLC & UHPLC · 19 May 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #13 · Analytics › Home & field testing · 7 May 2026 · 0 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #100 · Compounds › Tirzepatide · 27 Apr 2026 · 23 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Follow-up: State-level differences that actually matter Replied, post #4 · Regional › North America · 3 Apr 2026 · 0 likes post #3 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #28 · Clinical › Bloodwork · 1 Apr 2026 · 8 likes Picking up post #25: that is the part I would want checked first. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…
-
Five questions in one post gets you one answer — how to split them Replied, post #44 · Start Here › How to Ask · 31 Mar 2026 · 30 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #23 · Sourcing › Red flags · 29 Mar 2026 · 8 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #11 · Analytics › COA interpretation · 22 Mar 2026 · 0 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #76 · Research Methods › N-of-1 designs · 18 Mar 2026 · 0 likes Picking up post #73: that is the part I would want checked first. Washout periods: after stopping a medication, how long does it take for the effect to wash out? For…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #67 · Lounge › Introductions · 14 Mar 2026 · 0 likes Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce yourself before your first technical post either.
-
The most useful thing you learned here that was not the answer you came for Replied, post #27 · Lounge › Off topic · 14 Mar 2026 · 21 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #31 · Practice › Administration · 11 Mar 2026 · 32 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #8 · Compounds › Repair & healing peptides · 7 Mar 2026 · 0 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #27 · Practice › Administration · 16 Feb 2026 · 0 likes On post #23 — agreed on the reasoning, with one qualification. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always…
-
Run-in periods and the population they select — the long version Replied, post #2 · Evidence › Trials · 18 Jan 2026 · 15 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #57 · Pharmacology › Pharmacokinetics · 11 Jan 2026 · 0 likes post #56 is right about the mechanism and I think understates the practical bit. Fasting requirement for oral semaglutide: food and large fluid volumes reduce…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #121 · Documentation › Doc review · 28 Dec 2025 · 23 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here.
-
Specification in the result column: why that is a meaningful error Replied, post #84 · Analytics › COA interpretation · 6 Dec 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Heterogeneity as information rather than as a nuisance Replied, post #14 · Evidence › Meta-analyses · 2 Dec 2025 · 2 likes post #13 is right about the mechanism and I think understates the practical bit. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion…
-
Documentation that appears only after payment Replied, post #94 · Sourcing › Red flags · 2 Dec 2025 · 0 likes Coming back to post #92, because the follow-up matters more than the original answer. Safety documentation absent: a supplier that cannot provide information about…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #6 · marked as the solution · Meta › Site feedback · 22 Nov 2025 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Heterogeneity as information rather than as a nuisance Replied, post #2 · Evidence › Meta-analyses · 16 Nov 2025 · 5 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #17 · Analytics › Impurities & related substances · 16 Nov 2025 · 0 likes On post #13 — agreed on the reasoning, with one qualification. Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #22 · Compounds › Tirzepatide · 15 Nov 2025 · 21 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #19 · Research Methods › N-of-1 designs · 14 Nov 2025 · 0 likes Picking up post #16: that is the part I would want checked first. Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a…
-
[2026 update] What steady state means for the decision to escalate Replied, post #54 · Practice › Dosing & titration · 10 Nov 2025 · 10 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
NHS criteria and how they are applied in practice — the long version Replied, post #16 · Regional › UK & Ireland · 8 Nov 2025 · 24 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #22 · Data & Tools › Calculators · 29 Oct 2025 · 2 likes post #21 answers the question as asked. The question underneath it is different. The calculators maintained on this site are open-source and verifiable. They are…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #102 · Data & Tools › Calculators · 2 Sep 2025 · 0 likes I read post #100 twice before replying, because I had assumed the opposite. The calculators maintained on this site are open-source and verifiable. They are intended to…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #49 · Compounds › Semaglutide · 28 Aug 2025 · 3 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #118 · Wellbeing › Mental health · 25 Aug 2025 · 0 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #2 · Lounge › Off topic · 21 Aug 2025 · 8 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #114 · Practice › Storage & stability · 16 Aug 2025 · 0 likes This follows post #111 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #65 · Data & Tools › Calculators · 28 Jul 2025 · 8 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
-
Sodium, potassium and magnesium when intake drops Replied, post #25 · Nutrition & Training › Hydration & electrolytes · 21 Jun 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #100 · Compounds › Cagrilintide & amylin analogues · 15 Jun 2025 · 27 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #129 · Compounds › Semaglutide · 22 May 2025 · 4 likes On post #125 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #9 · Evidence › Journal club · 21 May 2025 · 7 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #28 · Evidence › Journal club · 7 May 2025 · 7 likes Worth separating two things that post #24 runs together. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not…
-
Reading a supplier's product description as a marketing document Replied, post #19 · Compounds › Other compounds · 4 May 2025 · 21 likes Worth separating two things that post #15 runs together. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The…
-
Counter-ion content and its effect on measured mass Replied, post #26 · Analytics › Mass spectrometry · 27 Apr 2025 · 1 like Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #11 · Evidence › Journal club · 19 Apr 2025 · 33 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The C-cell question: rodent findings and their human context Replied, post #5 · Compounds › Semaglutide · 4 Apr 2025 · 0 likes post #4 is right about the mechanism and I think understates the practical bit. The STEP programme populations were selected: enrollment criteria required baseline body…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #52 · Practice › Reconstitution · 2 Apr 2025 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #14 · Evidence › Journal club · 24 Mar 2025 · 1 like Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #83 · Analytics › Mass spectrometry · 9 Mar 2025 · 5 likes Worth separating two things that post #79 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #13 · Sourcing › Regulatory · 27 Feb 2025 · 2 likes post #12 is right about the mechanism and I think understates the practical bit. Research-use-only status is a legal classification, not a safety classification. It…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #3 · Pharmacology › Receptor biology · 23 Feb 2025 · 7 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Consistent declarations and why they matter more than clever ones Replied, post #51 · Sourcing › Logistics · 18 Feb 2025 · 6 likes Picking up post #48: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #11 · Compounds › Secretagogues & GH axis · 15 Feb 2025 · 1 like Coming back to post #9, because the follow-up matters more than the original answer. GHRH analogues versus ghrelin mimetics are often conflated but they are different…
-
Micronutrient status when intake falls substantially — a second dataset Replied, post #8 · Clinical › Bloodwork · 24 Jan 2025 · 4 likes This follows post #5 rather than contradicting it. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually…
-
Scheduled maintenance and what will be unavailable Replied, post #16 · Meta › Announcements · 15 Jan 2025 · 0 likes On post #12 — agreed on the reasoning, with one qualification. Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will…
-
Follow-up: Individual participant data versus aggregate data Replied, post #44 · Evidence › Meta-analyses · 9 Jan 2025 · 4 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
Oxidation pathways for methionine and tryptophan Replied, post #63 · Analytics › Impurities & related substances · 31 Dec 2024 · 21 likes post #62 is right about the mechanism and I think understates the practical bit. Residual solvents: traces of solvents used in purification. These are usually tested by…
-
A promotion I argued against, and why I lost Replied, post #44 · Documentation › Doc review · 29 Dec 2024 · 28 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
Body image changing more slowly than the body Replied, post #58 · Wellbeing › Mental health · 17 Dec 2024 · 3 likes Worth separating two things that post #54 runs together. When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function,…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #57 · Access › Insurance & coverage · 6 Dec 2024 · 20 likes Picking up post #54: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
When to suspect the method rather than the sample Replied, post #43 · Analytics › Method validation · 28 Nov 2024 · 14 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Coming back to: When to suspect the method rather than the sample Replied, post #3 · Analytics › Method validation · 27 Nov 2024 · 22 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #3 · Data & Tools › Calculators · 24 Nov 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #36 · Compounds › Semaglutide · 21 Nov 2024 · 0 likes post #35 answers the question as asked. The question underneath it is different. The SELECT trial changed the positioning because it was the first cardiovascular…
-
EMA product information as a primary source — does this still hold? Replied, post #58 · Regional › European Union · 16 Nov 2024 · 28 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Promotion criteria, and the one that stops most nominations Replied, post #93 · Documentation › Doc review · 23 Oct 2024 · 17 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Why a preprint's supplementary material is often the best part Replied, post #23 · Evidence › Preprints · 14 Sep 2024 · 33 likes I read post #21 twice before replying, because I had assumed the opposite. Preprints for speed: some important preliminary findings are posted as preprints to…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #56 · Sourcing › Independent verification · 13 Sep 2024 · 1 like When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Identical chromatograms across two different lots Replied, post #20 · Sourcing › Red flags · 30 Aug 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Chronic kidney disease and the FLOW result Replied, post #25 · Clinical › Comorbidities · 18 Aug 2024 · 10 likes Picking up post #22: that is the part I would want checked first. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #5 · Evidence › Journal club · 27 Jul 2024 · 1 like SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Cold packs, phase-change material, and what survives ten days Replied, post #38 · Sourcing › Logistics · 24 Jun 2024 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
The mass-error checker and its intended scope Replied, post #54 · Data & Tools › Calculators · 16 Jun 2024 · 29 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…